BOSTON SCIENTIFIC CORP 4
4 · BOSTON SCIENTIFIC CORP · Filed May 30, 2007
Insider Transaction Report
Form 4
BARTELL MARK C
SVP Global Sales/Mkt CRM
Transactions
- Sale
Common Stock
2007-05-25$15.75/sh−489,450$7,708,838→ 1,812 total - Sale
Common Stock
2007-05-25$15.75/sh−175,000$2,756,355→ 491,262 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-05-25−358,550→ 0 totalExercise: $13.23Exp: 2011-01-15→ Common Stock (358,550 underlying) - Exercise/Conversion
Common Stock
2007-05-25$14.30/sh+358,550$5,127,265→ 360,362 total - Exercise/Conversion
Common Stock
2007-05-25$15.06/sh+111,150$1,673,919→ 830,062 total - Sale
Common Stock
2007-05-25$15.75/sh−163,800$2,579,719→ 666,262 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-05-25−111,150→ 0 totalExercise: $15.06Exp: 2009-01-15→ Common Stock (111,150 underlying)
Holdings
- 38,770(indirect: By ESSOP)
Common Stock
- 468(indirect: By Spouse)
Common Stock
- 9,569(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Shares owned through ESSOP.
- [F2]Reflects Guidant ESSOP shares assumed by Boston Scientific in connection with its acquisition of Guidant.
- [F3]Reflects Guidant ESPP shares assumed by Boston Scientific in connection with its acquisition of Guidant.
- [F4]Shares owned by spouse through ESSOP.
- [F5]Reflects options to purchase common stock of Boston Scientific originally granted as options to purchase common stock of Guidant Corporation and assumed by Boston Scientific in connection with its acquisition of Guidant.